@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix sdis: . @prefix hgnc: . @prefix proteinModification: . @prefix psimod: . @prefix mesh: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 belv:variantOf hgnc:830; a proteinModification:, psimod:00696 . sub:_2 occursIn: mesh:D009132, species:9606; rdf:object sub:_1; rdf:predicate belv:positiveCorrelation; rdf:subject sdis:Type%20II%20diabetes; a rdf:Statement . sub:assertion rdfs:label "path(SDIS:\"Type II diabetes\") positiveCorrelation p(HGNC:ATP5B,pmod(P))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "In particular, we demonstrated that the catalytic beta-subunit of ATP synthase is phosphorylated in vivo and that the levels of a down-regulated ATP synthase beta-subunit phosphoisoform in diabetic muscle correlated inversely with fasting plasma glucose levels."; prov:wasQuotedFrom pubmed:12531894 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12531894; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:09.454+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }